Hyderabad, May 11, 2022: Hetero, India’s leading pharmaceutical company, today unveiled its new corporate logo, brand architecture, visual and verbal identity. With a people-first approach, this distinctive identity will guide and accelerate Hetero’s business growth and evolution.
Dr. Vamsi Krishna Bandi, Managing Director, Hetero Group of Companies, said: “Our new logo, is built around the idea of ‘Health for All’ and strengthens our ideology of 'focused interventions leading to exponential impact.' It uses circles as the primary visual anchor to represent the idea of accessibility and global reach”.
The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version. It continues to be red but with a warmer tone that shows Hetero’s passion and humane approach.
We defined why we exist in the form of a purpose statement, which is a reflection of our past, present and future. It is to keep…
At Hetero, our every action seeks to inspire human belief in accessibility and affordability of life-saving medicines across the world.
Dr. B. Partha Saradhi Reddy, Chairman, Hetero Group of Companies, said: “With unparalleled strengths in research, manufacturing, and marketing, we have been well-positioned to serve people regardless of geographies. Our new identity embodies this drive to expand our reach and capabilities in order to respond with agility to the world’s evolving health needs”.
The new logo is effective immediately and will be implemented across the Group’s companies, solutions, assets, services, and products in due course.
Hetero is a globally renowned vertically integrated pharmaceutical organization engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 30 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients (APIs) in the world. For more information on Hetero, please visit www.hetero.com.
For further details, please contact: